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Mango ginger (curcuma amada) inhibits collagen-induced arthritis by modulating
inflammatory cytokine levels in rats
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Background/aim: Mango ginger (MG: curcuma amada) has antioxidant and antiinflammatory activities. The aim was to evaluate the
antiarthritic potential efficacy of MG on collagen-induced arthritis.
Materials and methods: Twenty-one female Wistar-albino rats were divided into three groups. Arthritis was induced by intradermal
injections of type II collagen and Freund’s adjuvant. MG extract was orally administered starting from the first collagen injection.
TNF-α, IL-6, IL-17, obestatin, sclerostin, and DKK-1 serum levels were determined, and perisynovial inflammation and cartilage-bone
destruction in the paws were histologically evaluated. Moreover, joint tissue TNF-α, IL-17, NF-κB, and COX-2 levels were analyzed.
Results: TNF-α, IL-17, IL-6, and DKK-1 serum levels were increased, and obestatin and sclerostin serum levels were decreased in the
arthritis group compared to the control group. However, MG supplements decreased TNF-α, IL-17, IL-6, and DKK-1 serum levels and
increased obestatin and sclerostin serum levels. Similarly, while collagen injection increased tissue TNF-α, IL-17, NF-κB, and COX2 levels, MG decreased TNF-α, IL-17, and NF-κB levels. Moreover, MG ameliorated perisynovial inflammation and cartilage-bone
destruction in the paws.
Conclusion: MG ameliorates arthritis via actions on inflammatory ways and wingless (Wnt) signaling pathway. These results suggest
that MG may have a considerable potential efficacy for the treatment of rheumatoid arthritis.
Key words: Mango ginger, inflammation, collagen-induced arthritis, rheumatoid arthritis

1. Introduction
Rheumatoid arthritis (RA), a chronic and progressive
autoimmune disease, is characterized by inflammation
triggered by genetic and environmental factors [1]. The
most common clinical finding is joint involvement in RA.
The inflammatory process begins with the interaction of
innate immunity (macrophage, neutrophil, dendritic cell,
etc.) with acquired immunity (T and B lymphocytes) and
with fibroblast-like synoviocytes. This process becomes
chronic with the interaction of some signal transduction
pathways, the release of autoantibodies (rheumatoid factor
and anti-cyclic citrulline peptides), and proinflammatory
cytokines (tumor necrosis factor [TNF]-α, interleukin
[IL]-1β, IL-6, and IL-17) [2,3].
Wingless (Wnt) signaling pathway plays a very
important role in the regulation of the cell’s proliferation

and differentiation as well as bone homeostasis. Wnt
pathway expresses target genes and leads to the synthesis of
different proteins. Thus, cellular events are controlled such
as inhibition of cell proliferation, differentiation, apoptosis,
and angiogenesis [4,5]. Wnt pathway plays a crucial role
in RA pathogenesis. Sclerostin and Dickkopf (DKK)-1 are
extracellular proteins that inhibit this pathway [6,7].
Nuclear factor kappa B (NF-κB) activation plays
an important role in the initiation and maintenance of
inflammation in RA. NF-κB causes the release of some
mediators and enzymes by inducing transcription of genes
involved in inflammation, pain, and oxidative stress [8].
Obestatin is an anorectic peptide encoded by the same
gene of the ghrelin hormone. Obestatin is synthesized
in many tissues such as the stomach, small intestine,
hypothalamus, and pituitary. It has the opposite effect
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of ghrelin and suppresses appetite and reduces weight
gain [9]. It has been shown that obestatin levels may be
associated with some inflammatory markers in systemic
inflammatory diseases such as RA [10].
Treatment of RA is difficult because of the uncertainty
of underlying pathogenetic mechanisms and the variety of
clinical findings. Various herbal formulations have been
used since ancient times for the alternative treatment
research. Mango ginger (MG) is used as herbal medicine
to treat inflammation. MG has been reported to have many
effects such as anti-oxidant, anti-cancer, analgesic, and
antiinflammatory [11]. Therefore, this study was planned
to demonstrate whether MG has antiinflammatory effects
on an experimental arthritis model, collagen-induced
arthritis (CIA).
2. Material and methods
2.1. Animals
Twenty-one female Wistar albino rats (8 weeks old; 200–
220 g) were purchased from Animal Experimental Unit of
Fırat University. Rats were maintained on a 12 h light, 12
h dark cycle at a temperature of 22 ± 3 °C and a relative
humidity of 55% ± 5%. Animals received the standard
pellet diet as described previously [12] and water ad
libitum. The experimental procedures were approved by
the Ethical Committee of Animal Care of Firat University
(2016/15-147).
2.2. Study groups and applications
Rats were divided randomly into 3 groups (n = 7) as
control, arthritis+placebo, and arthritis+MG supplement
groups. Type 2 collagen from the chicken sternum (Sigma
Aldrich, St. Louis, USA) was dissolved in 0.1 M acetic
acid (to reach 1 mg/mL concentration of type 2 collagen).
The collagen solution was emulsified in an equal amount
of incomplete Freund’s Adjuvant (Difco Laboratories,
Detroit, USA) [13]. In arthritis + placebo and arthritis +
MG groups, this solution was given intradermally (total:
200 μg to each rat) to the rats from tail dorsal (100 μg
to each rat) and hindpaw (50 μg to each hindpaw), for
arthritis induction. Seven days after the first injection,
booster injection (100 μg to each rat) was applied in tail
dorsal. Rats in the third (arthritis+MG) group were orally
administered MG at a dose of 50 mg/kg/day (OmniActive
Health Technologies, Inc., Morristown, NJ, USA) starting
from the first collagen injection to 33rd day. The dose was
determined based on Ramachandran et al. [14]. MG was
administered by gavage, and saline solution was used as a
vehicle.
All rats were evaluated daily for arthritis development
and clinical arthritis scoring. Clinical arthritis score was
assessed by scoring 0–4 points [15].
All rats were sacrificed by decapitation on the 33rd
day and the study was terminated. Blood samples of the

rats were taken and centrifuged at 5000 rpm for 5 min.
The harvested sera were stored at –20 °C until the day of
analysis. In all groups, the hind paws were excised rapidly
from sacrificed rats for later histopathological and Western
blot analysis. Tissue samples were fixed with 10% formalin
solution for further pathological analysis. The tissues for
Western blot analysis were quickly frozen at –80 °C.
2.3. Histopathological analysis
Tissue samples, those fixed with formalin solution, were
decalcified with 10% nitric acid (30 days), then paraffin
blocks were prepared. Sections from the blocks were
stained with Hematoxylin-Eosine (H&E stain). Sections
were examined by a specialist pathologist under the light
microscope ×20, ×40, ×100, ×200, and ×400 magnifications
in the pathology laboratory to assess inflammatory cell
infiltration, pannus formation, and destruction of the
bones around the joints. Histopathological scoring was
performed (0– 4 score) [16].
2.4. Laboratory analyses
Routine serum laboratory assays (glucose, alanine
aminotransferase (ALT), aspartate aminotransferase
(AST), urea, creatinine, and lipid profiles) were determined
by the biochemical analyzer (Samsung LABGEO PT10,
Samsung Electronics Co, Suwon, Korea). Serum IL-17,
IL-6, TNF-α, DKK-1, sclerostin and obestatin levels
were analyzed by using commercially available enzymelinked immunosorbent assay (ELISA) kits according
to the recommended procedure by the manufacturer’s
instructions (Cayman Chemical, Ann Arbor, MI, USA).
2.5. Western blotting
Levels of TNF-α, IL-17, NF-κB, and COX-2 in joint tissue
samples were analyzed using Western blot technique.
In accordance with the purpose, the hind paws were
quickly harvested and frozen at –80 °C. The joint tissue
homogenates were prepared in ice-cold lysis buffer
containing 50 mM Tris-HCl (pH, 8.0), 5 mM EDTA, 0.26%
sodium deoxycholate, 1% Triton X-100, 150 mM NaCl, 50
mM sodium fluoride, 10 mM b-glycerophosphate, 0.1 mM
sodium orthovanadate, 50 μg/ml phenylmethylsulfonyl
fluoride, and 10 μg/mL leupeptin. The prepared
homogenates were incubated on ice for 40 min [16].
Sodium
dodecyl
sulfate-polyacrylamide
gel
electrophoresis
sample
buffer
containing
2%
b-mercaptoethanol was added to the supernatant. Equal
amounts of protein (50 μg) were electrophoresed and then
transferred to nitrocellulose membranes (Schleicher and
Schuell Inc., Keene, NH, USA). Nitrocellulose blots were
each washed in phosphate-buffered saline (PBS) for 5
min and blocked with 1% bovine serum albumin in PBS
for 1 h prior to administration of the primary antibody.
Antibodies against TNF-α, IL-17, NF-kB, COX-2, and
IL-17 (Abcam, Cambridge, UK) were diluted (1: 1000)
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in the same buffer containing 0.05% Tween-20. The
nitrocellulose membrane was incubated with protein
antibody overnight at 4 °C. The blots were washed and
the turbot peroxidase conjugated goat antimouse IgG
(Abcam, Cambridge, UK). Specific binding was detected
using H2O2 and diaminobenzidine, as substrates. Protein
loading was checked using a monoclonal mouse antibody
against β-actin antibody (A5316; Sigma Aldrich, St. Louis,
MO, USA). Blots were performed at least three times to
confirm the reproducibility of the results. Bands were
analyzed densitometrically using an image analysis system
(Image J; National Institute of Health, Bethesda, USA).
2.6. Statistical analysis
The sample size of the present study was seven per group
and it was calculated based on a power of 85% and a P
value of 0.05 (GPower 3.1). All analyses were performed
using the general linear model procedure. Differences
among groups were analyzed by Fisher’s post hoc test and
Mann–Whitney U test for categorical and continuous
variables, respectively.
3. Results
Swelling and erythema were observed around 13 to 15 days
after the first injection of collagen. The 15th day arthritis
score was significantly higher in arthritis and MG groups
than the control group (P < 0.001 and P < 0.05, respectively;
Table 1). The 15th day arthritis scores were decreased by
36% in the MG group when compared to the arthritis
group (P ˃ 0.05; Table 1). Arthritis scores of the 33rd day

were decreased by 44% in the MG group compared to the
arthritis group (P < 0.001). MG supplement ameliorated
the clinical findings of arthritis (Table 1).
3.1. Cytokine levels
Serum IL-6, TNF-α, and IL-17 levels were higher in the
arthritis group than the control group (P ˂ 0.001 for all
three). On the other hand, serum TNF-α, IL-6, and IL-17
levels were lower (36%, 29%, and 41%, respectively) in the
MG group when compared with the arthritis group (P <
0.001 for all three) (Table 2).
3.2. DKK-1 and sclerostin levels
Serum DKK-1 levels were higher in the arthritis group
compared to the control group (P < 0.001). Serum DKK-1
levels were 23% lower in the MG group when compared to
the arthritis group (P < 0.001). Serum sclerostin levels were
55% lower in the arthritis group compared to the control
group (P < 0.001). Serum sclerostin levels were 36% higher
in MG group when compared with the arthritis group (P
< 0.05) (Table 2).
3.3. Obestatin levels
Serum obestatin levels were 58% lower in the arthritis
group when compared to the control group (P < 0.001).
Serum obestatin levels were 21% higher in the MG group
when compared with the arthritis group, but there was no
statistically significant difference (Table 2; P ˃ 0.05).
3.4. Western blot analyzes
The tissue NF-κB levels were 77% higher in the arthritis
group when compared with the control group (Figure 1C).

Table 1. The effect of mango ginger extract on arthritis scores, inflammation score, and
biochemical parameters in rats with collagen-induced arthritis.
Parameters

Control

Arthritis

Mango ginger

15th day Arthritis Score

-

2.00 ± 0.38

1.29 ± 0.29

33rd day Arthritis Score

-

3.57 ± 0.20

2.00 ± 0.38##

Inflammation Score

-

4.43 ± 0.62

2.64 ± 0.46##

Blood glucose, mg/dL

97.57 ± 3.53

100.71 ± 3.43

98.43 ± 3.40

ALT, U/L

49.71 ± 5.64

50.86 ± 4.18

48.00 ± 2.10

AST, U/L

324.29 ± 19.11

326.86 ± 13.54

323.43 ± 15.09

Creatinine, mg/dL

1.72 ± 0.19

1.78 ± 0.10

1.74 ± 0.07

Cholesterol, mg/dL

94.43 ± 5.40

96.14 ± 6.38

93.86 ± 4.50

Triglycerides, mg/dL

115.29 ± 5.88

118.14 ± 5.48

116.29 ± 5.81

HDL-c, mg/dL

28.14 ± 2.01

26.71 ± 1.86

26.71 ± 2.04

LDL-c, mg/dL

41.29 ± 3.48

42.86 ± 2.32

42.00 ± 3.63

ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; HDL-c High-density
lipoprotein-cholesterol; LDL-c: Low-density lipoprotein-cholesterol.
The data presented as a mean ± standard deviation.
Mean values within the same row with are statistically different for ##P < 0.01 as compared
with arthritis group.
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Table 2. The effect of mango ginger extract on serum IL-6, TNF-α, obestatin, sclerostin, and DKK1 levels in rats with collagen-induced arthritis.
Parameters

Control

Arthritis

Serum IL-6, pg/mL

Mango ginger

11.04 ± 0.75

***

39.14 ± 2.83

27.71 ± 1.52*** ##

Serum IL-17, pg/mL

22.43 ± 1.66

60.29 ± 3.22***

35.86 ± 2.73** ###

Serum TNF-α, pg/mL

24.71 ± 1.73

52.43 ± 2.21

33.57 ± 1.60** ###

Obestatin, pg/mL

279.43 ± 14.43

118.71 ± 4.82***

143.71 ± 5.30***

Sclerostin, ng/mL

0.49 ± 0.03

0.22 ± 0.01

0.30 ± 0.02*** #

DKK-1, pg/mL

643.57 ± 32.49

1700.71 ± 25.27***

1318.29 ± 25.80*** ###

***

***

IL: Interleukin; TNF-α: Tumor necrosis factor alpha; DKK: Dickkopf - related protein.
Data were presented as mean ± standard deviation.
Mean values within same row with are statistically different for **P < 0.01, ***P < 0.001 as
compared with control group; #P < 0.05, ##P < 0.01, ###P < 0.001 as compared with arthritis group.

NF-κB levels were decreased by 30% in the MG group
when compared with the arthritis group (P ˂ 0.05). COX2 levels were 133% and 128% higher in arthritis and MG
group compared with the control group, respectively.
There was no difference between arthritis and MG groups
in terms of COX-2 levels (P ˃ 0.05) (Figure 1D). The joint
tissue TNF-α levels were increased by 35% in the arthritis
group when compared to the control group (Figure 1A).
The joint tissues TNF-α levels were decreased by 20% in
the MG group when compared with the arthritis group (P
˂ 0.05). The joint tissue IL-17 levels were 69% higher in
the arthritis group when compared with the control group
(P ˂ 0.05). The joint tissue IL-17 levels were 33% lower in
the MG group when compared with the arthritis group (P
< 0.05) (Figure 1B).
3.5. Histopathological evaluation
In the histopathological evaluation of the joint tissue
samples taken from rats, marked perisynovial inflammatory
cell infiltration and cartilage-bone destruction in the
arthritis group were observed (Figure 2A and 2B). There
was a decrease in the inflammatory cell infiltration and
bone-cartilage destruction in the MG group (Figure 2C).
The inflammation score was decreased by 40% in the MG
group when compared with the arthritis group (P ˂ 0.001).
4. Discussion
Rheumatoid arthritis is a disease that causes malfunctioning
of the joints as a result of inflammation and proliferation
of the synovial membrane. If not properly treated, it can
lead to serious deformities and disabilities. However, cure
or remission cannot be reached with available therapeutic
agents in all RA patients. Moreover, medical treatment
agents used in RA may have serious side effects such as
osteoporosis, hypertension, diabetes mellitus, infection,
and malignancy [17]. For this reason, the new treatment

option which is effective, reliable, and has a low side effect
is a necessity in RA.
Mango ginger is within the Zingiberaceae family
and Curcuma genus; it usually grows in tropical
regions. MG is also known as Curcuma amada. MG is
used as a traditional treatment modality in the world
because of its many useful biological activities such as
antimicrobial, antiinflammatory, antioxidant, antitumor,
hypotriglyceridemia, antiaggregation, and analgesia [18].
In an experimental arthritis study, MG has been shown
to reduce joint swelling, arthritic index, white blood cell
count, and erythrocyte sedimentation rate [19]. In another
experimental study, Mujumdar et al. [20] have demonstrated
that MG has dose-dependent antiinflammatory activity in
acute and chronic administration. In our study, there was
a decrease in arthritis scores in the MG group.
Activated T cells play an important role in RA
pathogenesis. Activation of T cells induces monocytes,
macrophages, and synovial fibroblasts and increases the
production of proinflammatory cytokines such as TNF-α,
IL-6, and IL-1. Activated T cells are responsible for going
on the inflammatory process. Th17 cells play a central
role in RA pathogenesis by producing IL-17 and TNF-α.
IL-17 stimulates synovial fibroblasts to produce IL-6 and
monocyte-macrophages to produce TNF-α. RANKL
(receptor activator of NF - kB ligand) is expressed on the
Th17 cells surface, so thus the conversion of nonresorptive
osteoclasts to resorptive osteoclasts is induced. As a
result, osteoclastogenesis is induced and bone-cartilage
destruction occurs [21]. TNF-α is one of the main cytokines
that play a role in the pathogenesis of RA. TNF-α blockade
has been shown to reduce bone-cartilage destruction
[22,23]. Consequently, therapeutic agents blocking TNF-α
have been developed and these agents are widely used in
routine practice to treat RA.
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Figure 1. The effect of mango ginger extracts on protein levels of tumor necrosis factor alpha (TNF-α;
Panel A), interleukin 17 (IL-17; Panel B), nuclear factor-kappa B (NF - kB; Panel C), and cyclooxygenase 2
(COX2; Panel D) in the study groups. The intensity of the bands was quantiﬁed by densitometric analysis
and β-actin was included to ensure equal protein loading. Data are expressed as percent of the control
value. Blots were repeated at least 3 times. *P < 0.05, **P < 0.01, as compared with the control group; #P <
0.05, ##P < 0.01 as compared with the arthritis group.

Figure 2. The effect of mango ginger extracts on histopathological changes (H & E × 40) in the study groups. Normal joint structure
in the control group (A). Marked perisynovial inflammatory cell infiltration and cartilage–bone destruction in the arthritis group (B).
Decreased perisynovial inflammation and synovial hyperplasia in the mango ginger group (C).

Interleukin-6 activates neutrophils, T cells, and
osteoclasts and increases the levels of acute phase proteins,
and thus IL-6 leads to joint destruction in RA [24]. High
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17 tissue levels of TNF-α, and IL-17 were decreased in the
group treated with MG. These cytokines are accepted to
orchestrate the pathogenesis of RA.
In RA, synovial fibroblasts produce inflammatory and
proliferative mediators. The Wnt pathway has an important
function in the activation of synovial fibroblasts [4].
DKK-1 is secreted from synovial fibroblasts in response
to inflammatory conditions. DKK-1 has an important
role in bone biology by suppressing osteoblastic activity
[25]. It also inhibits the Wnt signaling pathway and thus
reduces the formation of osteoprotegerin. Eventually, it
causes an increase in osteoclastic activity [26]. The DKK-1
expression has been shown to increase in the experimental
arthritis model [25]. Caetano –Lopes et al. [27] have
shown that DKK-1 expression in RA increases the bone
fragility. Besides, it is known that TNF-α and IL-6 increase
DKK-1 levels and thus they inhibit new bone formation
[28]. The preventive effects of antiTNF therapies on bone
damages are a consequence of their suppressive action
on serum levels of DKK-1 [reviewed in 29]. In our study,
serum DKK-1 levels increased in the arthritis group and
decreased in the MG group.
Sclerostin is a protein secreted from osteocytes
encoded by the SOST gene. It is an antagonist of the Wnt
pathway like DKK-1 and increases bone destruction by
suppressing the osteoblastic process [26]. Studies done
with sclerostin in RA have different results. In one study,
improvement of bone damage with sclerostin inhibitors
has been observed [30]. Different studies have shown that
there is no significant change in serum sclerostin levels
in RA compared to healthy controls [31,32]. Wehmeyer
et al. [33] have shown that the inhibitors of sclerostin
induce joint destruction by triggering TNF–α-dependent
inflammatory processes and thus lead to poor outcomes, in
patients with RA. In our study, sclerostin levels increased
in the MG group compared to the arthritis group. These
results suggest that MG affects Wnt pathway.
Nuclear factor kappa B plays an important role in
the regulation of the immune system by transcriptional
activation of certain proinflammatory cytokines. In
particular, activation of the classical NF-κB signaling
pathway induces the osteoclastic process [29]. Cytokine
production in patients with RA is dependent on NF-κB
[34]. In our study, NF-κB activation reduced with MG
treatment.
In RA, COX-2 is released from various cells, such as
monocytes, macrophages, synovial cells and fibroblasts
which are associated with inflammatory response, and
it causes joint damage [35]. The inhibition of COX-2

reduces synovial inflammation and thus prevents joint
damage. Furthermore, the COX-2 expression is regulated
by the NF-κB pathway. COX-2 levels were not sufficiently
reduced with MG treatment, in our study. This may be
related to the short duration of treatment or that selected
MG dose may be low [36,37]. In CIA model, MG inhibits
several inflammation-related ways such as NF-κB binding
activity, NF-κB dependent expression of cytokines (TNF-α,
IL-6, and IL-17), T and B lymphocytes, and macrophages
in synovial cells. It may be concluded that MG contains
a number of bioactive divergent substances which inhibit
inflammatory and osteoclastic activity.
Obestatin is associated with the inflammatory process
in some diseases as well as metabolic process. Obestatin
has antiinflammatory and antioxidant effects. It has been
shown that it decreases some proinflammatory cytokine
levels and inhibits inflammatory pathways [38,39]. Koca et
al. [10] have shown no significant difference in obestatin
levels between RA and healthy controls. In the same study,
it was shown that obestatin levels were higher in patients
with RA than Behçet’s disease [10]. In another study,
it has been shown that obestatin treatment reduces the
expression of vascular cell adhesion molecule-1 (VCAM
- 1) [40]. On the other hand, Alexandridis et al. [41] have
shown that serum obestatin levels are decreased in active
inflammatory bowel disease. In our study, obestatin level
was decreased in arthritis while MG treatment increased
serum obestatin level. Although controversial results
are reported in different studies, all these data we have
obtained suggest that the mechanisms underlying antiarthritic effects of MG may be related to obestatin.
As a result, in experimental arthritis model, MG
treatment decreases the levels of cytokines such as TNF-α,
IL-6, and IL-17. It also depletes NF-kB expression and
the level of serum DKK-1, which is the Wnt pathway
inhibitor. On the other hand, MG increases the serum
levels of sclerostin and obestatin. These results reveal that
MG applications alter several pathways that are associated
with RA pathogenesis. These results suggest that MG
therapy may be effective in RA treatment by suppressing
inflammatory and osteoclastic pathways.
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